Press Release Archive
Press Releases
July 2023
07.27.2023 Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy 07.21.2023 Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility 07.19.2023 Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate 07.18.2023 Corporate Partnerships Flagship Pioneering and Pfizer Partner to Accelerate Development of Innovative Medicines Targeting Unmet Needs
June 2023
06.28.2023 FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency 06.27.2023 FDA Accepts Pfizer’s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec 06.26.2023 Research and Pipeline Research Pfizer Provides Update on GLP-1-RA Clinical Development Program for Adults with Obesity and Type 2 Diabetes Mellitus 06.23.2023 Prescription Medicines Medicines FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents With Severe Alopecia Areata 06.22.2023 Financial Finance Pfizer Declares Third-Quarter 2023 Dividend 06.20.2023 Prescription Medicines Medicines Pfizer’s TALZENNA® in Combination with XTANDI® Receives U.S. FDA Approval 06.20.2023 Financial Finance Pfizer Invites Public to View and Listen to Webcast of August 1 Conference Call with Analysts 06.06.2023 Financial Finance Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.